TIDMHIK
RNS Number : 5520U
Hikma Pharmaceuticals Plc
07 April 2016
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the
notification relates
to (i) a
transaction notified
in accordance with
DTR 3.1.2 R,
(ii) a disclosure
made in accordance
LR 9.8.6R(1) or
(iii) a disclosure
made in accordance
with section 793 of
Name of the issuer the Companies Act
(2006).
HIKMA PHARMACEUTICALS
1. PLC 2. (i) & (iii)
---- ---------------------------------------- ---- ---------------------------
State whether notification
relates to a person
connected with a person
discharging managerial
Name of person discharging responsibilities/director
managerial named in 3 and identify
responsibilities/director the connected person
3. SAID DARWAZAH 4. N/A
---- ---------------------------------------- ---- ---------------------------
Indicate whether the
notification is in
respect of a holding Description of shares
of the person referred (including class),
to in 3 or 4 above debentures or derivatives
or in respect of a or financial instruments
nonbeneficial relating to shares
interest 1
ORDINARY SHARES OF
5. 3 ABOVE 6. 10P EACH
---- ---------------------------------------- ---- ---------------------------
Name of registered
shareholders(s) and,
if more than one, State the nature of
the number of shares the transaction
held by each of them
PURCHASE OF 60,000
VIDACOS NOMINEES LIMITED BY DARHOLD LIMITED,
ON BEHALF OF DARHOLD IN WHICH THE PDMR
7. LIMITED 8. HAS AN EQUITY STAKE.
---- ---------------------------------------- ---- ---------------------------
Percentage of issued
Number of shares, class acquired (treasury
debentures or financial shares of that class
instruments relating should not be taken
to shares acquired into account when
calculating percentage)
9. 60,000 10. 0.025%
---- ---------------------------------------- ---- ---------------------------
Percentage of issued
class disposed (treasury
Number of shares, shares of that class
debentures or financial should not be taken
instruments relating into account when
to shares disposed calculating percentage)
11. N/A 12. N/A
---- ---------------------------------------- ---- ---------------------------
Price per share or Date and place of
value of transaction transaction
13. GBP21.18p 14. 7 APRIL 2016, LONDON
---- ---------------------------------------- ---- ---------------------------
Total holding following
notification and total
percentage holding
following notification
(any treasury shares
should not be taken
into account when
calculating percentage)
13,132,373 (5.49%)
COMPRISING:
DIRECTLY, INCLUDING
CONNECTED PERSONS:
657,000 (0.27%) Date issuer informed
of transaction
INDIRECTLY THROUGH
DARHOLD LIMITED: 12,475,373
15. (5.22%) 16. 7 APRIL 2016
---- ---------------------------------------- ---- ---------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Date of grant Period during which
or date on which exercisable
17. N/A 18. N/A
---- --------------------------- ---- ------------------------------
Total amount paid Description of shares
(if any) for grant or debentures involved
of the option (class and number)
19. N/A 20. N/A
---- --------------------------- ---- ------------------------------
Exercise price (if
fixed at time of grant) Total number of shares
or or debentures over
indication that price which options held
is to be fixed at following notification
the time of exercise
21. N/A 22. N/A
---- --------------------------- ---- ------------------------------
Name of contact and
telephone number for
Any additional information queries
PETER SPEIRS 0207
23. N/A 24. 399 2772
---- --------------------------- ---- ------------------------------
Name of authorised official of issuer responsible
for making notification
Peter Speirs, Company Secretary
Date of notification 7 April 2016
--------------------------------------------------
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) An issuer making a notification in respect
of a transaction relating to the shares
or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect
of a derivative relating the shares of
the issuer should complete boxes 1 to
4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect
of options granted to a director/person
discharging managerial responsibilities
should complete boxes 1 to 3 and 17 to
24.
(4) An issuer making a notification in respect
of a financial instrument relating to
the shares of the issuer (other than a
debenture) should complete boxes 1 to
4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the
notification relates
to (i) a
transaction notified
in accordance with
DTR 3.1.2 R,
(ii) a disclosure
made in accordance
LR 9.8.6R(1) or
(iii) a disclosure
made in accordance
with section 793 of
Name of the issuer the Companies Act
(2006).
HIKMA PHARMACEUTICALS
1. PLC 2. (i) & (iii)
---- ---------------------------- ---- ---------------------------
State whether notification
relates to a person
connected with a person
discharging managerial
Name of person discharging responsibilities/director
(MORE TO FOLLOW) Dow Jones Newswires
April 07, 2016 11:08 ET (15:08 GMT)
managerial named in 3 and identify
responsibilities/director the connected person
3. MAZEN DARWAZAH 4. N/A
---- ---------------------------- ---- ---------------------------
Indicate whether the
notification is in
respect of a holding Description of shares
of the person referred (including class),
to in 3 or 4 above debentures or derivatives
or in respect of a or financial instruments
nonbeneficial relating to shares
interest 1
ORDINARY SHARES OF
5. 3 ABOVE 6. 10P EACH
---- ---------------------------- ---- ---------------------------
Name of registered
shareholders(s) and,
if more than one, State the nature of
the number of shares the transaction
held by each of them
PURCHASE OF 60,000
VIDACOS NOMINEES LIMITED BY DARHOLD LIMITED,
ON BEHALF OF DARHOLD IN WHICH THE PDMR
7. LIMITED 8. HAS AN EQUITY STAKE.
---- ---------------------------- ---- ---------------------------
Percentage of issued
Number of shares, class acquired (treasury
debentures or financial shares of that class
instruments relating should not be taken
to shares acquired into account when
calculating percentage)
9. 60,000 10. 0.025%
---- ---------------------------- ---- ---------------------------
Percentage of issued
class disposed (treasury
Number of shares, shares of that class
debentures or financial should not be taken
instruments relating into account when
to shares disposed calculating percentage)
11. N/A 12. N/A
---- ---------------------------- ---- ---------------------------
Price per share or Date and place of
value of transaction transaction
13. GBP21.18p 14. 7 APRIL 2016, LONDON
---- ---------------------------- ---- ---------------------------
Total holding following
notification and total
percentage holding
following notification
(any treasury shares
should not be taken
into account when
calculating percentage)
7,187,488 (3.00%)
COMPRISING:
DIRECTLY: 907,041
(0.38%) Date issuer informed
of transaction
INDIRECTLY THROUGH
DARHOLD LIMITED: 6,280,447
15. (2.62%) 16. 7 APRIL 2016
---- ---------------------------- ---- ---------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Date of grant Period during which
or date on which exercisable
17. N/A 18. N/A
---- --------------------------- ---- ------------------------------
Total amount paid Description of shares
(if any) for grant or debentures involved
of the option (class and number)
19. N/A 20. N/A
---- --------------------------- ---- ------------------------------
Exercise price (if
fixed at time of grant) Total number of shares
or or debentures over
indication that price which options held
is to be fixed at following notification
the time of exercise
21. N/A 22. N/A
---- --------------------------- ---- ------------------------------
Name of contact and
telephone number for
Any additional information queries
PETER SPEIRS 0207
23. N/A 24. 399 2772
---- --------------------------- ---- ------------------------------
Name of authorised official of issuer responsible
for making notification
Peter Speirs, Company Secretary
Date of notification 7 April 2016
--------------------------------------------------
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) An issuer making a notification in respect
of a transaction relating to the shares
or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect
of a derivative relating the shares of
the issuer should complete boxes 1 to
4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect
of options granted to a director/person
discharging managerial responsibilities
should complete boxes 1 to 3 and 17 to
24.
(4) An issuer making a notification in respect
of a financial instrument relating to
the shares of the issuer (other than a
debenture) should complete boxes 1 to
4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the
notification relates
to (i) a
transaction notified
in accordance with
DTR 3.1.2 R,
(ii) a disclosure
made in accordance
LR 9.8.6R(1) or
(iii) a disclosure
made in accordance
with section 793 of
Name of the issuer the Companies Act
(2006).
HIKMA PHARMACEUTICALS
1. PLC 2. (i) & (iii)
---- ---------------------------- ---- ---------------------------
State whether notification
relates to a person
connected with a person
discharging managerial
Name of person discharging responsibilities/director
managerial named in 3 and identify
responsibilities/director the connected person
3. MOHAMMED 'ALI' AL-HUSRY 4. N/A
---- ---------------------------- ---- ---------------------------
Indicate whether the
notification is in
respect of a holding Description of shares
of the person referred (including class),
to in 3 or 4 above debentures or derivatives
or in respect of a or financial instruments
nonbeneficial relating to shares
interest 1
ORDINARY SHARES OF
5. 3 ABOVE 6. 10P EACH
---- ---------------------------- ---- ---------------------------
Name of registered
shareholders(s) and,
if more than one, State the nature of
the number of shares the transaction
held by each of them
PURCHASE OF 60,000
VIDACOS NOMINEES LIMITED BY DARHOLD LIMITED,
ON BEHALF OF DARHOLD IN WHICH THE PDMR
7. LIMITED 8. HAS AN EQUITY STAKE.
---- ---------------------------- ---- ---------------------------
Percentage of issued
Number of shares, class acquired (treasury
debentures or financial shares of that class
instruments relating should not be taken
to shares acquired into account when
calculating percentage)
9. 60,000 10. 0.025%
---- ---------------------------- ---- ---------------------------
Percentage of issued
class disposed (treasury
Number of shares, shares of that class
debentures or financial should not be taken
instruments relating into account when
to shares disposed calculating percentage)
11. N/A 12. N/A
---- ---------------------------- ---- ---------------------------
Price per share or Date and place of
value of transaction transaction
(MORE TO FOLLOW) Dow Jones Newswires
April 07, 2016 11:08 ET (15:08 GMT)
13. GBP21.18p 14. 7 APRIL 2016, LONDON
---- ---------------------------- ---- ---------------------------
Total holding following
notification and total
percentage holding
following notification
(any treasury shares
should not be taken
into account when
calculating percentage)
5,779,967 (2.41%)
UNDER DYKB LIMITED
COMPRISING:
DIRECTLY: 1,162,811
(0.49%) Date issuer informed
of transaction
INDIRECTLY THROUGH
DARHOLD LIMITED: 4,617,156
15. (1.92%) 16. 7 APRIL 2016
---- ---------------------------- ---- ---------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Date of grant Period during which
or date on which exercisable
17. N/A 18. N/A
---- --------------------------- ---- ------------------------------
Total amount paid Description of shares
(if any) for grant or debentures involved
of the option (class and number)
19. N/A 20. N/A
---- --------------------------- ---- ------------------------------
Exercise price (if
fixed at time of grant) Total number of shares
or or debentures over
indication that price which options held
is to be fixed at following notification
the time of exercise
21. N/A 22. N/A
---- --------------------------- ---- ------------------------------
Name of contact and
telephone number for
Any additional information queries
PETER SPEIRS 0207
23. N/A 24. 399 2772
---- --------------------------- ---- ------------------------------
Name of authorised official of issuer responsible
for making notification
Peter Speirs, Company Secretary
Date of notification 7 April 2016
--------------------------------------------------
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) An issuer making a notification in respect
of a transaction relating to the shares
or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect
of a derivative relating the shares of
the issuer should complete boxes 1 to
4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect
of options granted to a director/person
discharging managerial responsibilities
should complete boxes 1 to 3 and 17 to
24.
(4) An issuer making a notification in respect
of a financial instrument relating to
the shares of the issuer (other than a
debenture) should complete boxes 1 to
4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBUGDSRGGBGLR
(END) Dow Jones Newswires
April 07, 2016 11:08 ET (15:08 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
